These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31225872)

  • 1. Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients.
    Vitellius G; Delemer B; Caron P; Chabre O; Bouligand J; Pussard E; Trabado S; Lombes M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5205-5216. PubMed ID: 31225872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
    Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A
    J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sp1 transcription factor is crucial for the expression of 11beta-hydroxysteroid dehydrogenase type 2 in human placental trophoblasts.
    Li JN; Ge YC; Yang Z; Guo CM; Duan T; Myatt L; Guan H; Yang K; Sun K
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E899-907. PubMed ID: 21411560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing hormone induces expression of 11beta-hydroxysteroid dehydrogenase type 2 in rat Leydig cells.
    Wang Q; Zhang P; Gao HB
    Reprod Biol Endocrinol; 2009 May; 7():39. PubMed ID: 19409113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity.
    Alikhani-Koupaei R; Fouladkou F; Fustier P; Cenni B; Sharma AM; Deter HC; Frey BM; Frey FJ
    FASEB J; 2007 Nov; 21(13):3618-28. PubMed ID: 17551100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Hussey M; Holleran G; Smith S; Sherlock M; McNamara D
    Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation.
    Pizzolo F; Friso S; Morandini F; Antoniazzi F; Zaltron C; Udali S; Gandini A; Cavarzere P; Salvagno G; Giorgetti A; Speziali G; Choi SW; Olivieri O
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1234-41. PubMed ID: 26126204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 Expression by Hedgehog Ligand Contributes to the Conversion of Cortisol Into Cortisone.
    Zhu H; Zou C; Fan X; Xiong W; Tang L; Wu X; Tang C
    Endocrinology; 2016 Sep; 157(9):3529-39. PubMed ID: 27379371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.
    Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ
    J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ERK1/2 signaling pathway regulates 11beta-hydroxysteroid dehydrogenase type 2 expression in human trophoblast cells through a transcriptional mechanism.
    Guan H; Sun K; Yang K
    Biol Reprod; 2013 Oct; 89(4):92. PubMed ID: 23966319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension.
    De Santis D; Castagna A; Danese E; Udali S; Martinelli N; Morandini F; Veneri M; Bertolone L; Olivieri O; Friso S; Pizzolo F
    Front Endocrinol (Lausanne); 2021; 12():681974. PubMed ID: 34497581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor delta suppresses 11beta-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells.
    Julan L; Guan H; van Beek JP; Yang K
    Endocrinology; 2005 Mar; 146(3):1482-90. PubMed ID: 15591138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1.
    Kostadinova RM; Nawrocki AR; Frey FJ; Frey BM
    FASEB J; 2005 Apr; 19(6):650-2. PubMed ID: 15659537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo.
    Skobowiat C; Sayre RM; Dowdy JC; Slominski AT
    Br J Dermatol; 2013 Mar; 168(3):595-601. PubMed ID: 23363016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent mineralocorticoid excess syndrome in a Brazilian boy caused by the homozygous missense mutation p.R186C in the HSD11B2 gene.
    Coeli FB; Ferraz LF; Lemos-Marini SH; Rigatto SZ; Belangero VM; de-Mello MP
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1277-81. PubMed ID: 19169481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11β-HSD2 SUMOylation Modulates Cortisol-Induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation.
    Jiménez-Canino R; Lorenzo-Díaz F; Odermatt A; Bailey MA; Livingstone DEW; Jaisser F; Farman N; Alvarez de la Rosa D
    Endocrinology; 2017 Nov; 158(11):4047-4063. PubMed ID: 28938454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone enhances basal and TNF-alpha-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11beta-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells.
    Kimura H; Li X; Torii K; Okada T; Kamiyama K; Mikami D; Takahashi N; Yoshida H
    Nephrol Dial Transplant; 2009 Jun; 24(6):1759-65. PubMed ID: 19153071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine vasopressin stimulates 11beta-hydroxysteroid dehydrogenase type 2 expression in the mineralocorticosteroid target cells.
    Rubis B; Krozowski Z; Trzeciak WH
    Mol Cell Endocrinol; 2006 Aug; 256(1-2):17-22. PubMed ID: 16872738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent mineralocorticoid excess syndrome: an overview.
    Palermo M; Quinkler M; Stewart PM
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):687-96. PubMed ID: 15761540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.